NEUROSCIENCE RESEARCH DAY 2023
THE GREAT DEBATE:
Is the amyloid hypothesis of Alzheimer’s disease (AD) sufficient to explain AD pathology?
Jane Rylett, PhD
Dr. Jane Rylett is a Distinguished University Professor at the Western University and Scientist in the Translational Neuroscience Group at Robarts Research Institute. She is past-Chair of the Department of Physiology and Pharmacology at the Schulich School of Medicine & Dentistry. Following a PhD in Pharmacology, she trained in neurophysiology at University College London, England and neurochemistry at the Max-Planck-Institute for Biophysical Chemistry, Germany. She was recruited to Western University as the Rubinoff Scholar in Geriatrics. Dr. Rylett is a cellular and molecular neurobiologist studying the consequences of age-related changes in brain and neurodegenerative diseases, and recognized for studies on cholinergic neurobiology and Alzheimer disease. Research in her laboratory focuses on mechanisms regulating chemical communication in the nervous system in health, normal aging and disease and the impact on cognitive function. Dr. Rylett has served on Boards of Directors of the Alzheimer Societies of Canada and Ontario and on taskforces for international endeavours for Alzheimer Disease research. She has been leader of the Canadian Consortium on Neurodegeneration in Aging (CCNA) Theme 1 – Prevention. She was appointed as an inaugural College Chair of the CIHR College of Reviewers as Executive Vice-Chair. She is a Fellow of the Canadian Academy of Health Sciences and was appointed as the Scientific Director of the CIHR Institute of Aging in August, 2019.
Affiliations:
Professor, Department of Physiology and Pharmacology
Scientist, Translational Neuroscience Group, Robarts Research Institute
Scientific Director, CIHR Institute of Aging